CIK 0000885725 · Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042695240
- Phone
- 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-28 | Woodworth Emily SVP, Global Controller and CAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,218 | 0 | ||
| 2025-02-25 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Gift | −340 | 178,342 | ||
| 2025-02-25 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Sale 10b5-1 | −2,688 | $104.00 | $280K | 25,766 |
| 2025-02-24 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Gift | −1,700 | 178,682 | ||
| 2025-02-24 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Gift | +340 | 5,234 | ||
| 2025-02-24 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Sale 10b5-1 | −4,675 | $104.25 | $487K | 28,454 |
| 2025-02-24 | Zane Ellen M Director | Sale 10b5-1 | −13,586 | $104.23 | $1.4M | 34,944 |
| 2025-02-21 | Brown Vance R SVP, GC and Corp. Secretary | Sale 10b5-1 | −4,826 | $104.64 | $505K | 45,845 |
| 2025-02-20 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Gift | −1,000 | 180,382 | ||
| 2025-02-19 | Sorenson John Bradley EVP, Global Operations | Sale 10b5-1 | −3,303 | $105.19 | $347K | 20,991 |
| 2025-02-19 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Sale 10b5-1 | −1,510 | $105.35 | $159K | 33,129 |
| 2025-02-19 | Brennan Daniel J. EVP and CFO | Option exercise 10b5-1 | +18,533 | $24.55 | $455K | 251,151 |
| 2025-02-19 | Brennan Daniel J. EVP and CFO | Option exercise 10b5-1 | +16,865 | $17.26 | $291K | 268,016 |
| 2025-02-19 | Brennan Daniel J. EVP and CFO | Option exercise 10b5-1 | +15,642 | $27.09 | $424K | 283,658 |
| 2025-02-19 | Brennan Daniel J. EVP and CFO | Option exercise 10b5-1 | +9,483 | $40.12 | $380K | 293,141 |
| 2025-02-19 | Brennan Daniel J. EVP and CFO | Sale 10b5-1 | −67,333 | $105.24 | $7.1M | 225,808 |
| 2025-02-19 | Brennan Daniel J. EVP and CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,642 | 31,285 | ||
| 2025-02-19 | Brennan Daniel J. EVP and CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,483 | 37,934 | ||
| 2025-02-19 | Brennan Daniel J. EVP and CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,865 | 0 | ||
| 2025-02-19 | Brennan Daniel J. EVP and CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,533 | 37,067 |
Page 16 of 40 · 791 trades